Skip to main content
EMV CAPITAL PLC logo

EMV CAPITAL PLC — Investor Relations & Filings

Ticker · EMVC ISIN · GB00BN4R5Q82 LEI · 213800N5WD46G1Y7I458 IL Financial and insurance activities
Open in API
Filings indexed 547 across all filing types
Latest filing 2023-11-13 Director's Dealing
Country GB United Kingdom
Listing IL EMVC

About EMV CAPITAL PLC

https://www.emvcapital.com/

EMV Capital PLC is a venture capital investment group specializing in deep tech and life sciences. The firm identifies, invests in, and builds high-growth, IP-rich companies with an international portfolio, focusing on sectors including industrial technology, healthcare, and sustainability. It employs a capital-efficient investment strategy that combines syndicated investments, direct balance sheet funding, and managed funds to support companies from their early stages through to successful exit. EMV Capital engages in proactive portfolio management, often taking board positions and working closely with company leadership. It provides extensive value creation services, including support for fundraising, exit readiness, IP strategy, and corporate collaborations, to drive growth and maximize returns for investors through strategic exits.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification of a share purchase by a company director (Mr. Ed Hooper). It explicitly follows the UK Market Abuse Regulation disclosure requirements for transactions by persons discharging managerial responsibilities (PDMR). This falls directly under the 'Director's Dealing' category.
2023-11-13 English
PDS Biotech Announces Updated Survival Data
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement issued by NetScientific PLC. It reports on clinical trial results from its portfolio company, PDS Biotechnology. While it contains detailed scientific data, it is fundamentally a press release distributed via a regulatory news service to inform the market of these developments. It does not constitute a full financial report, audit, or proxy statement. Given that it is a general regulatory announcement regarding corporate news, it falls under the RNS category.
2023-11-09 English
Ventive secures c.£900,000 investment
Regulatory Filings Classification · 98% confidence The document is a regulatory announcement (RNS) from NetScientific PLC regarding a capital investment in its portfolio company, Ventive. It details the fundraising amount, the nature of the investment (equity and convertible loans), and the impact on NetScientific's portfolio valuation. This fits the definition of a 'Capital/Financing Update' as it describes specific fundraising activities and capital structure changes for the company's portfolio.
2023-11-06 English
Change of Adviser
Regulatory Filings Classification · 100% confidence The document is a short announcement regarding the appointment of a new nominated adviser and broker for NetScientific plc. This type of corporate update regarding professional service providers does not fit into specific categories like financial reports or shareholder voting results. Therefore, it is classified as a general regulatory announcement under the RNS category.
2023-11-02 English
PDS Preliminary Biomarker Study Results
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the RNS Reach service. It announces preliminary biomarker study results for a portfolio company (PDS Biotechnology) of NetScientific PLC. It provides a summary of clinical trial data and includes a link to the full announcement on the company's website. Since it is a press release announcing news rather than a formal regulatory filing, financial report, or management report, it falls under the RNS (Regulatory News Service) category as a general regulatory announcement.
2023-10-23 English
Exercise of Options
Share Issue/Capital Change Classification · 100% confidence The document is an RNS announcement from NetScientific PLC regarding the exercise of share options by a former director and the subsequent application for the admission of new ordinary shares to the AIM market. This falls under the category of share issuance and capital changes, specifically categorized as 'Share Issue/Capital Change' (SHA).
2023-10-13 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.